Hypoxia-induced degradation of FTO promotes apoptosis by unmasking RACK1-mediated activation of MTK1-JNK1/2 pathway

Chengyu Li1, Zhaojun Liu1, Chen Fu1

  • 1College of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing 210095, China.

PubMed
Abstract

Insights

The RNA demethylase FTO prevents cell death during hypoxia by moving to the cytoplasm and interacting with RACK1. This protein interaction inhibits the MTK1-JNK1/2 pathway, thus blocking apoptosis.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Hypoxia (insufficient oxygen) triggers apoptosis (programmed cell death).
  • The RNA demethylase FTO has known anti-apoptotic effects.
  • FTO's non-RNA demethylase functions, especially protein interactions during hypoxia, are not well understood.

Purpose of the Study:

  • To investigate the mechanism by which FTO protects cells from apoptosis under hypoxic conditions.
  • To explore FTO's role beyond its RNA demethylase activity.

Main Methods:

  • Cell culture (NIH/3T3, MEF, mouse granulosa cells) under hypoxia.
  • Inhibition of degradation pathways (proteasome, autophagy) and RNA interference (ATG7, NEDD4, FTO).
  • Mass spectrometry and co-immunoprecipitation to identify FTO-interacting proteins.
  • Cellular fractionation and microscopy for FTO localization.
  • Flow cytometry for apoptosis assessment.
  • Functional assays using FTO inhibitors and mutants lacking demethylase activity.

Main Results:

  • Hypoxia induces FTO's translocation from the nucleus to the cytoplasm.
  • FTO degradation is regulated by ATG7 and NEDD4, activating both ubiquitin-proteasome and autophagic-lysosomal pathways.
  • Cytoplasmic FTO binds RACK1, disrupting the RACK1-MTK1 interaction.
  • This disruption inhibits JNK1/2 activation, preventing hypoxia-induced apoptosis.

Conclusions:

  • FTO exhibits a novel cytoplasmic function in preventing apoptosis during hypoxia.
  • This function involves disrupting the RACK1-MTK1-JNK1/2 signaling cascade.
  • FTO's role extends beyond RNA demethylation, highlighting its importance in protein-protein interactions.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K